Etiometry

The Etiometry Platform has received at least ten FDA clearances for its AI-driven risk analytics and clinical pathway automation tools. It aggregates real-time physiologic data from ICU patients to provide actionable insights that help clinicians anticipate patient deterioration or improvement. Clinical studies have shown the platform can reduce length of stay by up to 36%, decrease ICU readmissions by up to 41%, reduce ventilation time by up to 30%, and shorten vasoactive infusion duration by nearly a third. Over 150 studies have been enabled using the platform. Note that these results are observational; the system aids but does not independently improve outcomes. The technology has been adopted by leading academic medical centers and top-ranked children’s hospitals.